Thomas Richard Fuerst, SVP, Chief Scientific Officer at PHARMATHENE, INC (PIP), bought 5,000 shares at $1.27 ($6K) on 2011-11-22, disclosed to the SEC on 2011-11-23.
Open-market purchase of $6k PIP by SVP, Chief Scientific Officer. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.